ZNF262 inhibitors primarily consist of small molecules that target various signaling pathways involved in cell survival, apoptosis, and cytoskeletal organization. These compounds, while not directly inhibiting ZNF262, can influence the biological processes and pathways where ZNF262 is implicated. The compounds range from specific kinase inhibitors, like Stat3 inhibitor V, stattic and LY 294002, to broader spectrum immunosuppressants like Cyclosporin A and Azathioprine. The indirect inhibition mechanism of these compounds involves modulating pathways that intersect with the functional realm of ZNF262. For example, Stat3 inhibitor V, stattic targets STAT3, a crucial player in cytokine signaling and apoptosis, processes where ZNF262 has been implicated. By modulating STAT3 activity, Stattic could influence the overall cellular response to cytokines and apoptosis, thereby indirectly affecting ZNF262's function. Similarly, Wortmannin and LY 294002, as PI3K inhibitors, disrupt signaling pathways that are vital for cell survival and apoptosis, intersecting with the role of ZNF262 in these processes.
Inhibitors like PD 98059 and U0126 target the MAPK pathway, a key signaling cascade involved in cell growth, differentiation, and apoptosis. Since ZNF262 has been noted for its role in inhibiting interferon-gamma induced apoptosis, modulation of this pathway could have an indirect impact on ZNF262's function. Additionally, Y-27632, free base, a ROCK inhibitor, directly targets cytoskeletal organization, aligning with ZNF262's role in cell morphology regulation. These inhibitors, by targeting various signaling molecules and pathways, provide an indirect approach to modulate the activity and functions of ZNF262. This strategy is crucial for understanding the complex network of cellular signaling in which ZNF262 operates, especially in the context of apoptosis and cell morphology. While direct inhibition of ZNF262 remains a challenge, these compounds offer valuable insights and tools for exploring the broader biological implications related to ZNF262's function in cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Inhibits STAT3, a signaling molecule involved in cytokine signaling and apoptosis regulation. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that can modulate cytokine production and apoptosis pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, affecting pathways involved in cell survival and apoptosis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, impacting cell survival mechanisms that could intersect with ZNF262 pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, a kinase in the MAPK pathway, which may influence apoptosis and cell morphology. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, impacting stress responses and apoptosis, potentially influencing ZNF262 functions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, affecting inflammatory responses and apoptosis pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, directly affecting cytoskeletal organization and cell morphology. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress and can influence cell survival pathways, potentially intersecting with ZNF262. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, impacting cell growth and survival, possibly intersecting with ZNF262 functions. | ||||||